The role of Xeloda in metastasic breast cancer

by Cortés-Funes, H
Published 2005

Neratinib, an irreversible pan erB receptor tyrosine kinase inhibitor active for advanced HER2+ breast cancer

by Cortés-Funes, H, Mendiola, C, Manso, L, Ciruelos, E
Published 2009

Circulating epithelial tumor cells in patients with metastatic breast cancer treated with bevacizumab

by Manso, L, Ciruelos, E, Rodríguez, A, Diaz, J, Mendiola, C, López-Martín, JA, Cortes-Funes, H
Published 2009

Getting deep in the luminal B breast cancer subtype and its ki67 cut-off value

by Ciruelos, E, Castaneda, C, Pascual, T, Andrés, E, Gomez, HL, Manso, L, Valdivieso, N, Ghanem, I, Cortes-Funes, H
Published 2011

Lobular carcinoma of the breast: outcome of 205 patients

by Vega, E, Ciruelos, E, Valdiviezo, N, Mendiola, C, Manso, L, Ghanem, I, Dorta, M, Pascual, T, Flores, C, Cortés-Funes, H
Published 2011

Efficacy and safety of the administration of bevacizumab in combination with first-line chemotherapy for the treatment of advanced breast carcinoma: ATHENA MO19391 study results in...

by Ciruelos, EM, López-Vivanco, G, Peláez, I, Rifa, J, Santaballa, A, González, S, Segui, MA, Jara, C, Alvarez, I, Cortés-Funes, H
Published 2009

First-in-man phase I trial of two schedules of the novel synthetic tetrahydroisoquinoline alkaloid PM00104 (Zalypsis) in patients with advanced solid tumours

by Yap, T A, Cortes-Funes, H, Shaw, H, Rodriguez, R, Olmos, D, Lal, R, Fong, P C, Tan, D S, Harris, D, Capdevila, J, Coronado, C, Alfaro, V, Soto-Matos, A, Fernández-Teruel, C, Siguero, M, Tabernero, J M, Paz-Ares, L, de Bono, J S, López-Martin, J A
Published 2012